Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Abzug

Concepts (407)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
148
3.580
Why?
HIV Infections
26
2022
2487
2.230
Why?
Antiretroviral Therapy, Highly Active
9
2017
282
2.060
Why?
Pneumococcal Vaccines
5
2021
134
2.000
Why?
Pregnancy Complications, Infectious
14
2015
265
1.820
Why?
Antiviral Agents
11
2021
639
1.760
Why?
Enterovirus
9
2019
70
1.500
Why?
Hematopoietic Stem Cell Transplantation
4
2021
575
1.270
Why?
Immunologic Memory
3
2013
311
1.200
Why?
Pneumococcal Infections
3
2013
96
1.150
Why?
Immunization, Secondary
4
2021
76
1.140
Why?
Oxadiazoles
4
2015
32
1.050
Why?
Paralysis
4
2018
66
0.920
Why?
Child
52
2022
17711
0.820
Why?
Sinusitis
7
2013
157
0.760
Why?
Vaccination
4
2017
962
0.750
Why?
Mucositis
1
2018
18
0.730
Why?
Triazoles
2
2018
144
0.730
Why?
Meningoencephalitis
1
2017
25
0.700
Why?
Influenza, Human
5
2015
462
0.700
Why?
Antibodies, Bacterial
4
2013
137
0.680
Why?
Myelitis
4
2019
94
0.670
Why?
Anti-Retroviral Agents
7
2018
196
0.670
Why?
Theilovirus
4
2000
6
0.660
Why?
Graft vs Host Disease
1
2018
229
0.630
Why?
Encephalitis
1
2017
123
0.620
Why?
Influenza A Virus, H1N1 Subtype
3
2015
136
0.620
Why?
Neonatal Sepsis
1
2015
3
0.600
Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.600
Why?
Central Nervous System Viral Diseases
4
2019
62
0.600
Why?
Influenza Vaccines
3
2015
409
0.580
Why?
Herpes Simplex
4
2017
97
0.580
Why?
Immunocompromised Host
5
2021
218
0.570
Why?
Disease Outbreaks
6
2019
284
0.570
Why?
Neuromyelitis Optica
1
2015
89
0.560
Why?
Placenta
6
2000
568
0.540
Why?
Infant, Newborn
25
2018
5080
0.520
Why?
CD4 Lymphocyte Count
8
2022
299
0.510
Why?
Neuromuscular Diseases
3
2019
99
0.510
Why?
Humans
85
2022
113846
0.510
Why?
Measles Vaccine
1
2012
19
0.490
Why?
Infant
26
2020
8090
0.490
Why?
Adolescent
35
2022
18736
0.490
Why?
Drug Discovery
1
2013
131
0.490
Why?
Mucormycosis
3
2005
21
0.480
Why?
Child, Preschool
26
2022
9717
0.480
Why?
RNA, Viral
12
2013
598
0.440
Why?
Meningococcal Vaccines
2
2012
43
0.440
Why?
Female
60
2022
63035
0.440
Why?
Cardiovirus Infections
2
2000
3
0.440
Why?
Viral Vaccines
2
2009
78
0.430
Why?
Male
51
2022
60993
0.430
Why?
Oxazoles
4
2015
36
0.410
Why?
Hepatitis B Vaccines
1
2009
43
0.400
Why?
AIDS-Related Opportunistic Infections
3
2015
122
0.390
Why?
Viral Load
7
2017
470
0.390
Why?
Bacterial Vaccines
1
2009
65
0.370
Why?
Fatigue Syndrome, Chronic
1
2008
19
0.360
Why?
Pertussis Vaccine
1
2007
21
0.360
Why?
Poliomyelitis
2
1997
27
0.350
Why?
Communicable Diseases, Emerging
1
2008
30
0.350
Why?
Mycetoma
2
2004
5
0.340
Why?
Rhinitis
3
2009
114
0.330
Why?
Viremia
5
2021
127
0.330
Why?
Fetus
3
2000
680
0.320
Why?
Immunoglobulins, Intravenous
3
1997
150
0.310
Why?
Pregnancy
16
2021
5290
0.300
Why?
Antibodies, Viral
5
2022
526
0.290
Why?
Anti-Bacterial Agents
3
2013
1331
0.290
Why?
Enterovirus B, Human
3
2001
26
0.280
Why?
Anti-HIV Agents
4
2017
681
0.280
Why?
Meningitis, Viral
2
2004
24
0.280
Why?
Maxillary Sinusitis
2
2004
8
0.280
Why?
Maus Elberfeld virus
3
1993
5
0.270
Why?
Cytomegalovirus
2
2016
144
0.260
Why?
Global Health
2
2018
339
0.250
Why?
Acquired Immunodeficiency Syndrome
2
2017
225
0.250
Why?
Placenta Diseases
2
1995
13
0.250
Why?
Interferon-gamma
2
2015
804
0.240
Why?
Centralized Hospital Services
1
2001
5
0.240
Why?
Antifungal Agents
3
2014
136
0.230
Why?
Oseltamivir
2
2012
12
0.230
Why?
Fetal Diseases
3
2000
192
0.230
Why?
Hepatitis, Viral, Human
1
2001
28
0.230
Why?
United States
13
2021
12329
0.220
Why?
Pneumonia, Viral
2
2021
354
0.220
Why?
Retrospective Studies
13
2021
11340
0.210
Why?
Research Support as Topic
1
2001
125
0.210
Why?
Streptococcus pneumoniae
3
2014
131
0.210
Why?
Colorado
7
2021
4581
0.210
Why?
Ethmoid Sinusitis
1
1999
2
0.210
Why?
Intracranial Hemorrhages
1
2000
67
0.200
Why?
Hydrops Fetalis
1
1999
16
0.200
Why?
Uterine Diseases
1
1999
15
0.200
Why?
Neurodevelopmental Disorders
1
2021
109
0.200
Why?
Drug Resistance, Microbial
1
1999
68
0.200
Why?
Young Adult
14
2017
10971
0.200
Why?
Embryonic Development
1
2000
134
0.190
Why?
Polymerase Chain Reaction
4
2016
1100
0.190
Why?
Mastoiditis
2
2014
6
0.190
Why?
Enterovirus D, Human
2
2018
65
0.190
Why?
Blood Coagulation Disorders
1
2001
226
0.190
Why?
Fluoxetine
1
2018
45
0.180
Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
13
0.180
Why?
Nervous System Diseases
2
2019
260
0.180
Why?
Arboviruses
1
2017
10
0.180
Why?
Double-Blind Method
3
2015
1673
0.180
Why?
Biliary Atresia
1
2020
213
0.180
Why?
Nucleic Acid Hybridization
6
1991
207
0.180
Why?
Allografts
1
2018
106
0.170
Why?
Hospitals, Pediatric
1
2001
500
0.170
Why?
HIV-1
2
2015
804
0.170
Why?
Disease Transmission, Infectious
1
2018
61
0.170
Why?
Enzyme-Linked Immunosorbent Assay
2
2013
909
0.170
Why?
Antibodies, Monoclonal
2
2022
1302
0.170
Why?
Administration, Intravenous
1
2018
145
0.170
Why?
In Situ Hybridization
4
2000
342
0.170
Why?
Treatment Outcome
9
2020
9002
0.170
Why?
Acyclovir
2
2015
117
0.170
Why?
Endoscopy
1
1999
238
0.170
Why?
Sexual Maturation
1
2017
55
0.170
Why?
Immunization, Passive
1
1997
79
0.170
Why?
Cytomegalovirus Retinitis
1
2016
16
0.170
Why?
Postoperative Complications
2
2016
2116
0.170
Why?
Clinical Trials as Topic
1
2001
1009
0.160
Why?
Antibodies, Neutralizing
2
2022
173
0.160
Why?
Practice Guidelines as Topic
2
2022
1529
0.160
Why?
Respiratory Syncytial Virus Infections
1
1997
90
0.160
Why?
Nasal Mucosa
2
2009
93
0.160
Why?
Adoption
1
2016
49
0.150
Why?
Brain
3
2017
2686
0.150
Why?
Mice, Inbred ICR
4
1997
118
0.150
Why?
Hyperlipidemias
1
2017
146
0.150
Why?
Gastrointestinal Diseases
1
2018
205
0.150
Why?
Congenital Abnormalities
2
2010
68
0.150
Why?
Adult
17
2022
31979
0.150
Why?
Follow-Up Studies
7
2018
4906
0.150
Why?
Candidemia
1
2015
6
0.150
Why?
Diagnosis, Differential
2
2017
1432
0.150
Why?
Sexually Transmitted Diseases
1
2017
165
0.150
Why?
DNA, Viral
2
2016
442
0.150
Why?
Lymphocyte Subsets
1
2015
88
0.150
Why?
Ganciclovir
1
2015
48
0.150
Why?
Lymphopenia
1
2015
57
0.150
Why?
Muscle Hypotonia
1
2015
31
0.150
Why?
Oropharynx
1
2015
40
0.140
Why?
Child Development
2
2017
471
0.140
Why?
Cranial Nerve Diseases
1
2015
45
0.140
Why?
Hearing Loss, Sensorineural
1
2015
51
0.140
Why?
Chi-Square Distribution
2
2013
572
0.140
Why?
Adenovirus Infections, Human
2
1991
17
0.140
Why?
Incidence
6
2017
2470
0.140
Why?
Risk Factors
10
2021
9050
0.140
Why?
Liver Transplantation
1
2020
718
0.140
Why?
Rectum
1
2015
151
0.140
Why?
Controlled Clinical Trials as Topic
1
2013
30
0.140
Why?
Beclomethasone
1
1993
26
0.130
Why?
Puberty, Delayed
1
2013
5
0.130
Why?
Mycoses
1
2014
72
0.130
Why?
Antibody Affinity
1
2013
56
0.130
Why?
Giant Cells
1
1993
22
0.130
Why?
Hemagglutination Inhibition Tests
1
2013
40
0.130
Why?
Candidiasis, Invasive
1
2012
4
0.130
Why?
Cytomegalovirus Infections
1
2015
188
0.130
Why?
Intensive Care Units, Pediatric
1
2015
207
0.130
Why?
Candida
1
2012
33
0.130
Why?
Orthomyxoviridae
1
2012
28
0.130
Why?
Chickenpox
1
1993
98
0.130
Why?
Viral Plaque Assay
1
2012
26
0.120
Why?
Hospital Design and Construction
1
1992
5
0.120
Why?
Neutralization Tests
1
2012
72
0.120
Why?
Aircraft
1
1992
27
0.120
Why?
Bacterial Infections
2
2009
217
0.120
Why?
Ureaplasma urealyticum
1
1991
3
0.120
Why?
Drug Resistance, Viral
1
2012
103
0.120
Why?
Gestational Age
4
2015
770
0.120
Why?
HIV
1
2013
206
0.120
Why?
Chlamydia trachomatis
1
1991
31
0.120
Why?
Chorioamnionitis
1
1991
38
0.110
Why?
CD4-Positive T-Lymphocytes
2
2017
1074
0.110
Why?
Severity of Illness Index
4
2021
2828
0.110
Why?
Prospective Studies
7
2017
6250
0.110
Why?
Trophoblasts
1
1993
171
0.110
Why?
Decision Support Techniques
1
2015
388
0.110
Why?
Peritoneovenous Shunt
1
1990
1
0.110
Why?
Meningitis, Aseptic
1
1990
14
0.110
Why?
Poliovirus Vaccine, Oral
1
1990
19
0.110
Why?
Maternal-Fetal Exchange
2
2007
168
0.110
Why?
Rimantadine
1
2010
4
0.110
Why?
Cohort Studies
5
2022
5011
0.110
Why?
Respiratory Tract Infections
3
2016
267
0.110
Why?
Legionnaires' Disease
1
1990
6
0.110
Why?
Biomarkers
1
2021
3501
0.110
Why?
Adamantane
1
2010
20
0.100
Why?
Poliovirus
1
1990
79
0.100
Why?
Hepatitis B Antibodies
1
2009
10
0.100
Why?
Cross Infection
1
1992
204
0.100
Why?
Meningitis
1
1990
68
0.100
Why?
Mice
8
2000
15641
0.100
Why?
T-Lymphocytes
2
2015
1846
0.100
Why?
Administration, Oral
3
2012
798
0.090
Why?
South Africa
1
2009
151
0.090
Why?
Maxillary Sinus
2
2009
12
0.090
Why?
Mucor
2
2005
8
0.090
Why?
Acute Kidney Injury
1
2015
613
0.090
Why?
Age Factors
4
2017
3330
0.090
Why?
Body Fluids
1
1987
66
0.090
Why?
Drug Administration Schedule
2
2015
825
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2022
634
0.080
Why?
Virus Diseases
1
2009
181
0.080
Why?
Organ Transplantation
1
2009
142
0.080
Why?
Evidence-Based Medicine
3
2021
728
0.080
Why?
Aspergillosis
2
2014
30
0.080
Why?
Reverse Transcriptase Inhibitors
1
2007
83
0.080
Why?
Mitochondrial Diseases
1
2007
68
0.080
Why?
Zygomycosis
1
2006
6
0.080
Why?
Carotid Artery Thrombosis
1
2005
6
0.080
Why?
Randomized Controlled Trials as Topic
2
2004
1136
0.070
Why?
Statistics as Topic
1
2006
365
0.070
Why?
Chronic Disease
5
2009
1681
0.070
Why?
Drug Therapy, Combination
2
2007
1004
0.070
Why?
Herpesvirus 7, Human
1
2004
5
0.070
Why?
International Cooperation
2
2018
183
0.070
Why?
Drug Resistance, Fungal
1
2004
6
0.070
Why?
Scedosporium
1
2004
2
0.070
Why?
Roseolovirus Infections
1
2004
6
0.070
Why?
Longitudinal Studies
3
2018
2692
0.070
Why?
Herpesvirus 6, Human
1
2004
13
0.070
Why?
Respiratory Syncytial Viruses
2
1997
47
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2004
76
0.070
Why?
Animals
9
2000
35394
0.070
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
164
0.070
Why?
Vaccines, Conjugate
2
2014
52
0.060
Why?
Infant, Premature, Diseases
2
1997
89
0.060
Why?
Biological Availability
1
2003
159
0.060
Why?
Probability
1
2003
341
0.060
Why?
Risk Assessment
2
2020
3147
0.060
Why?
Growth Disorders
1
2022
68
0.060
Why?
Bacteria, Aerobic
1
2001
6
0.060
Why?
Drug Combinations
1
2022
300
0.060
Why?
Prenatal Exposure Delayed Effects
1
2007
467
0.060
Why?
Disease Models, Animal
3
2000
3910
0.060
Why?
Reference Values
1
2003
877
0.060
Why?
Personnel Staffing and Scheduling
1
2001
89
0.060
Why?
Income
1
2022
165
0.060
Why?
Case-Control Studies
3
2015
3369
0.050
Why?
Adenosine Monophosphate
1
2021
51
0.050
Why?
Drug Approval
1
2021
72
0.050
Why?
Alanine
1
2021
104
0.050
Why?
RNA Probes
2
1991
17
0.050
Why?
Disseminated Intravascular Coagulation
1
2000
33
0.050
Why?
United States Food and Drug Administration
1
2021
179
0.050
Why?
Systemic Inflammatory Response Syndrome
1
2021
77
0.050
Why?
Picornaviridae Infections
2
1990
27
0.050
Why?
Remission Induction
1
2020
265
0.050
Why?
Amniotic Fluid
2
1991
75
0.050
Why?
Necrosis
1
2000
232
0.050
Why?
Fungi
2
2014
119
0.050
Why?
Pharyngitis
1
1999
23
0.050
Why?
Otitis Media with Effusion
1
1999
21
0.050
Why?
Pseudallescheria
1
1999
3
0.050
Why?
Cerebrospinal Fluid
2
2004
95
0.050
Why?
Tissue and Organ Procurement
1
2020
144
0.050
Why?
Opportunistic Infections
1
1999
53
0.050
Why?
Zidovudine
2
2010
80
0.050
Why?
Living Donors
1
2020
202
0.050
Why?
Diabetes Mellitus, Type 1
2
2005
3307
0.050
Why?
Chlamydiaceae Infections
1
2017
1
0.040
Why?
Epidemiological Monitoring
1
2018
48
0.040
Why?
Nutrition Disorders
1
1997
26
0.040
Why?
Dose-Response Relationship, Drug
1
2003
2229
0.040
Why?
Otitis Media
1
1999
126
0.040
Why?
Spinal Cord
1
2000
406
0.040
Why?
Time Factors
1
2009
7060
0.040
Why?
Abortion, Spontaneous
1
1997
76
0.040
Why?
Internationality
1
2018
150
0.040
Why?
Reoperation
1
1999
538
0.040
Why?
Ophthalmoscopy
1
2016
25
0.040
Why?
Sex Factors
2
2017
1997
0.040
Why?
Antigens, Viral
1
2017
184
0.040
Why?
B-Lymphocytes
2
2015
832
0.040
Why?
Encephalomyelitis
1
2016
7
0.040
Why?
Plasma Cells
2
2009
63
0.040
Why?
Multicenter Studies as Topic
1
1997
222
0.040
Why?
Acute Disease
1
1999
1000
0.040
Why?
Heart
1
2000
685
0.040
Why?
Enzyme-Linked Immunospot Assay
1
2015
42
0.040
Why?
Immune Tolerance
2
1999
362
0.040
Why?
Malnutrition
1
2016
55
0.040
Why?
AIDS Dementia Complex
1
2015
55
0.040
Why?
Caribbean Region
1
2015
24
0.040
Why?
Hematologic Neoplasms
1
2016
121
0.040
Why?
North America
1
2016
274
0.040
Why?
Coinfection
1
2016
109
0.040
Why?
Molecular Diagnostic Techniques
1
2016
95
0.040
Why?
Encephalitis, Varicella Zoster
1
2015
20
0.040
Why?
Encephalitis, Herpes Simplex
1
2015
21
0.040
Why?
Audiometry
1
2015
33
0.040
Why?
Latin America
1
2015
70
0.040
Why?
Transplantation, Homologous
1
2016
490
0.040
Why?
Evaluation Studies as Topic
1
1995
226
0.040
Why?
Papillomavirus Infections
1
2017
222
0.040
Why?
Papillomavirus Vaccines
1
2017
189
0.040
Why?
Patient Outcome Assessment
1
2016
124
0.040
Why?
Biopsy
3
2009
1065
0.040
Why?
Physical Conditioning, Animal
1
1997
232
0.040
Why?
Neutropenia
1
2015
133
0.040
Why?
Canada
1
2015
336
0.040
Why?
C-Reactive Protein
1
2017
363
0.030
Why?
Microscopy, Electron
1
1995
464
0.030
Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
51
0.030
Why?
Odds Ratio
1
2017
1064
0.030
Why?
Metabolic Diseases
1
2015
112
0.030
Why?
Infusions, Intravenous
1
2015
412
0.030
Why?
Pandemics
1
2021
881
0.030
Why?
Combined Modality Therapy
3
2005
1243
0.030
Why?
Administration, Intranasal
1
1993
89
0.030
Why?
Infant, Premature
1
1997
449
0.030
Why?
Mortality
1
2015
328
0.030
Why?
Multivariate Analysis
1
2017
1599
0.030
Why?
Electromyography
1
2015
330
0.030
Why?
Epidemiologic Studies
1
2012
59
0.030
Why?
Sexual Behavior
1
2017
450
0.030
Why?
Sequence Analysis, DNA
1
2016
798
0.030
Why?
Prognosis
1
2001
3544
0.030
Why?
Tomography, X-Ray Computed
2
1999
2380
0.030
Why?
Neisseria meningitidis
1
2012
18
0.030
Why?
Oncology Service, Hospital
1
1992
16
0.030
Why?
Meningococcal Infections
1
2012
22
0.030
Why?
Ventilation
1
1992
31
0.030
Why?
Ureaplasma Infections
1
1991
3
0.030
Why?
Mycoplasma Infections
1
1991
15
0.030
Why?
Amniocentesis
1
1991
26
0.030
Why?
T-Lymphocyte Subsets
1
2015
450
0.030
Why?
Europe
1
2012
351
0.030
Why?
Microbial Viability
1
2012
76
0.030
Why?
Logistic Models
1
2017
2053
0.030
Why?
Adenoviruses, Human
1
1991
28
0.030
Why?
Chlamydia Infections
1
1991
57
0.030
Why?
Flow Cytometry
1
2015
1184
0.030
Why?
Respirovirus Infections
1
1990
13
0.030
Why?
Paramyxoviridae Infections
1
1990
14
0.030
Why?
Hospitals, University
1
1991
194
0.030
Why?
Rhinovirus
1
1990
37
0.030
Why?
Anti-Infective Agents
1
2013
234
0.030
Why?
Inpatients
1
2014
335
0.030
Why?
Comorbidity
1
2016
1601
0.030
Why?
Benzoxazines
1
2010
28
0.030
Why?
Cyclopropanes
1
2010
79
0.030
Why?
Lymphocyte Activation
1
2015
1165
0.030
Why?
Legionella
1
1990
7
0.030
Why?
Alkynes
1
2010
56
0.030
Why?
Leukemia
1
1992
214
0.030
Why?
Immunohistochemistry
1
1995
1831
0.030
Why?
Population Surveillance
1
1993
439
0.030
Why?
Hospitals
1
2014
468
0.030
Why?
Dermatomyositis
1
1989
23
0.030
Why?
Sensitivity and Specificity
1
1995
1930
0.020
Why?
Magnetic Resonance Imaging
2
2015
3049
0.020
Why?
Cells, Cultured
1
1997
4429
0.020
Why?
Peroxidase
1
2009
207
0.020
Why?
Natural Killer T-Cells
1
2009
57
0.020
Why?
Staining and Labeling
1
2009
171
0.020
Why?
Muscles
1
1989
331
0.020
Why?
Seasons
1
1990
439
0.020
Why?
Respiratory Tract Diseases
1
1990
158
0.020
Why?
Picornaviridae
1
1988
18
0.020
Why?
Ribonucleases
1
1987
57
0.020
Why?
Central Nervous System
1
2010
248
0.020
Why?
HIV Reverse Transcriptase
1
2007
30
0.020
Why?
Lamivudine
1
2007
56
0.020
Why?
Cross-Sectional Studies
1
2016
4275
0.020
Why?
Cavernous Sinus
1
2005
13
0.020
Why?
Telencephalon
1
2005
19
0.020
Why?
Antigens, CD
1
2009
508
0.020
Why?
Infectious Disease Transmission, Vertical
1
2007
133
0.020
Why?
Orbit
1
2005
42
0.020
Why?
Paranasal Sinuses
1
2005
58
0.020
Why?
Exocrine Glands
1
2004
5
0.020
Why?
Basement Membrane
1
2004
34
0.020
Why?
Prevalence
1
2010
2407
0.020
Why?
Cell Count
1
2004
334
0.020
Why?
RNA
1
1988
776
0.020
Why?
Neutrophils
1
2009
1324
0.020
Why?
Lymphocytes
1
2004
392
0.010
Why?
Eosinophils
1
2004
269
0.010
Why?
Penicillin Resistance
1
2001
8
0.010
Why?
Macrophages
1
2009
1343
0.010
Why?
beta-Lactamases
1
2001
21
0.010
Why?
Haemophilus influenzae
1
2001
49
0.010
Why?
Staphylococcus
1
2001
71
0.010
Why?
Drug Resistance, Multiple, Bacterial
1
2001
64
0.010
Why?
Drug Resistance, Bacterial
1
2001
153
0.010
Why?
Nasal Decongestants
1
1999
9
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
1999
37
0.010
Why?
Steroids
1
1999
136
0.010
Why?
Recurrence
1
1999
967
0.010
Why?
Anti-Inflammatory Agents
1
1999
460
0.010
Why?
Patient Selection
1
1999
694
0.010
Why?
RNA, Antisense
1
1988
24
0.010
Why?
DNA, Recombinant
1
1988
47
0.010
Why?
Sequence Homology, Nucleic Acid
1
1988
170
0.010
Why?
Aged
1
2006
20109
0.010
Why?
Virus Replication
1
1988
434
0.000
Why?
Middle Aged
1
2006
28753
0.000
Why?
Cell Line
1
1988
3016
0.000
Why?
DNA
1
1988
1417
0.000
Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)